Alba Fricke

Alba Fricke

Auto-generated profile, based on publicly available information

Alba Fricke

Department of Plastic and Hand Surgery, University of Freiburg Medical Center, Faculty of Medicine, Hugstetter Strasse 55, 79106, Freiburg, Germany.

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2012 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
PDPhilipp Diehl
Philipp Diehl
AFAlba Fricke
Alba Fricke
LSLaura Sander
Laura Sander
JSJohannes Stamm
Johannes Stamm
NBNicole Bassler
Nicole Bassler
KPKarlheinz Peter
Karlheinz Peter
Circulating microRNAs (miRNAs) have attracted major interest as biomarkers for cardiovascular diseases. Since RNases are abundant in circulating blood, there needs to be a mechanism protecting miRNAs from degradation. We hypothesized that microparticles (MP) represent protective transport vehicles for miRNAs and that these are specifically packaged by their maternal cells. Conventional plasma preparations, such as the ones used for biomarker detection, are shown to contain substantial numbers of platelet-, leucocyte-, and endothelial cell-derived MP. To analyse the widest spectrum of miRNAs, Next Generation Sequencing was used to assess miRNA profiles of MP and their corresponding stimulated and non-stimulated cells of origin. THP-1 (monocytic origin) and human umbilical vein endothelial cell (HUVEC) MP were used for representing circulating MP at a high purity. miRNA profiles of MP differed significantly from those of stimulated and non-stimulated maternal THP-1 cells and HUVECs, respectively. Quantitative reverse transcription–polymerase chain reaction of miRNAs which have been associated with cardiovascular diseases also demonstrated significant differences in miRNA profiles between platelets and their MP. Notably, the main fraction of miRNA in plasma was localized in MP. Furthermore, miRNA profiles of MP differed significantly between patients with stable and unstable coronary artery disease. Circulating MP represent transport vehicles for large numbers of specific miRNAs, which have been associated with cardiovascular diseases. miRNA profiles of MP are significantly different from their maternal cells, indicating an active mechanism of selective ‘packaging’ from cells into MP. These findings describe an interesting mechanism for transferring gene-regulatory function from MP-releasing cells to target cells via MP circulating in blood.

1 July 2015 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
VPV. Penna
V. Penna
AFA. Fricke
A. Fricke
NIN. Iblher
N. Iblher
SES.U. Eisenhardt
S.U. Eisenhardt
GSG.B. Stark
G.B. Stark

7 August 2015 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
AFAlba Fricke
Alba Fricke
PUPrisca V. Ullrich
Prisca V. Ullrich
JHJürgen Heinz
Jürgen Heinz
DPDietmar Pfeifer
Dietmar Pfeifer
JSJutta Scholber
Jutta Scholber
DBDavid Braig
David Braig
Synovial sarcoma account for approximately 10 % of all soft-tissue tumors and occur most frequently in young adults. A specific translocation in this sarcoma induces fusion of the SYT gene on chromosome 18 to the SSX genes on chromosome X, leading to proliferation of the tumor cells. The need for non-invasive biomarkers indicating recurrence and activity of this disease has sparked research into short non-coding RNA known as microRNA (miRNA). Blood samples of patients with active synovial sarcoma and of synovial sarcoma patients in complete remission as well as of healthy donors and patients with active leiomyosarcoma, MPNST, Ewing sarcoma and liposarcoma were collected. Whole blood RNA was extracted and samples of patients with active synovial sarcoma and of healthy donors were analyzed using an Affymetrix GeneChip miRNA Array v. 4.0. qRT-PCR was carried out to confirm a panel of miRNAs which where differentially expressed in the miRNA array. This miRNA-panel was further evaluated in patients with synovial sarcoma in complete remission and patients with active leiomyosarcoma, MPNST, Ewing sarcoma and liposarcoma as well as in an independent cohort of synovial sarcoma patients. Unsupervised hierarchical clustering of the miRNA arrays separated patients with active synovial sarcoma from healthy controls. A panel of seven miRNAs (miR-99a-5p, miR-146b-5p, miR-148b-3p, miR-195-5p, miR-223-3p, miR-500b-3p and miR-505-3p) was further validated by qRT-PCR to be significantly upregulated in synovial sarcoma patients. Moreover, most of the analyzed miRNAs were shown to be significantly upregulated in synovial sarcoma patients compared to leiomyosarcoma, MPNST, Ewing sarcoma and liposarcoma patients. Validation of the miRNA panel in an independent cohort of synovial sarcoma patients confirmed higher expression levels compared to healthy controls and patients in complete remission. Our results have identified a specific whole blood miRNA signature that may serve as an independent biomarker for the diagnosis of local recurrence or distant metastasis of synovial sarcoma. It even distinguishes synovial sarcoma from other sarcoma subtypes, thus potentially serving as a specific biomarker for synovial sarcoma.

18 February 2019 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
DBDavid Braig
David Braig
CBCaroline Becherer
Caroline Becherer
CBChristiane Bickert
Christiane Bickert
MBMoritz Braig
Moritz Braig
RCRainer Claus
Rainer Claus
SESteffen U. Eisenhardt
Steffen U. Eisenhardt

9 March 2017 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
AFA. Fricke
A. Fricke
GLG. M. Lehner
G. M. Lehner
GSG. B. Stark
G. B. Stark
VPV. Penna
V. Penna

29 May 2018 in Cancer Biomarkers
Verified
Journal Article
Closed access
PDF file
AFA. Fricke
A. Fricke
ACA.F.V. Cimniak
A.F.V. Cimniak
PUP.V. Ullrich
P.V. Ullrich
CBC. Becherer
C. Becherer
CBC. Bickert
C. Bickert
SES.U. Eisenhardt
S.U. Eisenhardt
BACKGROUND: Liposarcoma constitute about 13% of all soft tissue sarcoma and are associated with a high risk of metastases. As the preoperative differentiation between benign and malign lipomatous tumors is restricted to magnetic resonance imaging, co